Replication-competent murine retroviruses induce various types of hematopoietic tumors upon inoculation into mice. Recombination studies using molecularly cloned, viral genomes show that the long terminal repeat (LTR) is the primary genetic determinant of the viral disease inducing phenotype. Transcriptional tissue specificity of several viral LTRs shows an excellent correlation with the type of tumor induced by each virus. The central focus of the work described in this proposal is an assessment of the role of tissue specific differences in transcriptional activity in leukemogenicity. The nature of the molecular events involved in tissue specificity will be studied in detail primarily using the thymomagenic virus, SL3-3, and the non-leukemogenic virus, Akv. These studies will focus on identification of sequences at the single nucleotide level that are responsible for differences in tissue specificity and on identification of proteins that interact differentially with enhancer elements in the LTR. These studies are expected to lead to insight into the normal regulation of cell-type specific gene expression. The means which tissue specific regulation of gene expression alters viral leukemogenicity will also be studied in detail. From the standpoint of viral genetics, these studies are aimed at identifying the minimal changes necessary to convert a non- leukemogenic virus into one that induces thymic lymphomas. Two mechanisms by which altered tissue specificity could determine leukemogenicity will be investigated. One is whether transcriptional elements alter viral tissue tropism, while the other is whether these elements alter oncogene expression in a manner that alters tumorigenicity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA044822-05
Application #
3187640
Study Section
Experimental Virology Study Section (EVR)
Project Start
1987-05-01
Project End
1995-04-30
Budget Start
1991-05-01
Budget End
1992-04-30
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Heslin, David J; Murcia, Pablo; Arnaud, Frederick et al. (2009) A single amino acid substitution in a segment of the CA protein within Gag that has similarity to human immunodeficiency virus type 1 blocks infectivity of a human endogenous retrovirus K provirus in the human genome. J Virol 83:1105-14
Kim, Rachel; Trubetskoy, Alla; Suzuki, Takeshi et al. (2003) Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. J Virol 77:2056-62
Lenz, J; Su, M; Mizrachi, Y et al. (2001) V3 variation in HIV-seropositive patients receiving a V3- targeted vaccine. AIDS 15:577-81
Rulli, K; Lobelle-Rich, P A; Trubetskoy, A et al. (2001) Tissue distribution and timing of appearance of polytropic envelope recombinants during infection with SL3-3 murine leukemia virus or its weakly pathogenic SL3DeltaMyb5 mutant. J Virol 75:522-6
Barbulescu, M; Turner, G; Su, M et al. (2001) A HERV-K provirus in chimpanzees, bonobos and gorillas, but not humans. Curr Biol 11:779-83
Turner, G; Barbulescu, M; Su, M et al. (2001) Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol 11:1531-5
Beaty, R M; Rulli, K; Bost, K L et al. (1999) High levels of IL-4 and IL-10 mRNA and low levels of IL-2, IL-9 and IFN-gamma mRNA in MuLV-induced lymphomas. Virology 261:253-62
Martiney, M J; Rulli, K; Beaty, R et al. (1999) Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus. J Virol 73:7599-606
Rubinstein, A; Mizrachi, Y; Pettoello-Mantovani, M et al. (1999) Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugates. J Acquir Immune Defic Syndr 22:467-76
Trubetskoy, A M; Okenquist, S A; Lenz, J (1999) R region sequences in the long terminal repeat of a murine retrovirus specifically increase expression of unspliced RNAs. J Virol 73:3477-83

Showing the most recent 10 out of 26 publications